The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients

Molecules

Volumn 17, Issue 1, 2012, Pages 688-702

  Sheehan, Nancy L ^a,b   Van Heeswijk, Rolf P G ^c   Foster, Brian C ^d,e   Akhtar, Humayoun ^f   Singhal, Neera ^c   Seguin, Isabelle ^c   DelBalso, Lina ^b   Bourbeau, Marc ^c   Chauhan, Bobby M ^d,e   Boulassel, Mohammed Rachid ^b   Burger, David M ^g   Lalonde, Richard G ^b   Cameron, Donald William ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d Office of Science Laboratory   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

carotene; HIV; Interaction; Nelfinavir; Pharmacokinetics

Indexed keywords

BETA CAROTENE; DRUG DERIVATIVE; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; M8 NELFINAVIR; M8-NELFINAVIR; NELFINAVIR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DIET SUPPLEMENTATION; DRUG STABILITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; MULTICENTER STUDY; VIROLOGY; VIRUS LOAD;

ADULT; AREA UNDER CURVE; BETA CAROTENE; DIETARY SUPPLEMENTS; DRUG STABILITY; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; NELFINAVIR; VIRAL LOAD;

EID: 84856149488     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17010688     Document Type: Article

References (38)

1. Singhal, N.; Austin, J. A clinical review of micronutrients in hiv infection. J. Int. Assoc. Physicians AIDS Care (Chic. Ill) 2002, 1, 63-75.
2. Fairfield, K.M.; Eisenberg, D.M.; Davis, R.B.; Libman, H.; Phillips, R.S. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in hiv-infected patients. Arch. Intern. Med. 1998, 158, 2257-2264. (Pubitemid 28512500)
3. Bogden, J.D.; Baker, H.; Frank, O.; Perez, G.; Kemp, F.; Bruening, K.; Louria, D. Micronutrient status and human immunodeficiency virus (hiv) infection. Ann. N. Y. Acad. Sci. 1990, 587, 189-195. (Pubitemid 20249277)
4. Pace, G.W.; Leaf, C.D. The role of oxidative stress in hiv disease. Free Radic Biol. Med. 1995, 19, 523-528.
5. Keating, J.; Bjarnason, I.; Somasundaram, S.; Macpherson, A.; Francis, N.; Price, A.B.; Sharpstone, D.; Smithson, J.; Menzies, I.S.; Gazzard, B.G. Intestinal absorptive capacity, intestinal permeability and jejunal histology in hiv and their relation to diarrhoea. Gut 1995, 37, 623-629.
6. Austin, J.; Singhal, N.; Voigt, R.; Smaill, F.; Gill, M.J.; Walmsley, S.; Salit, I.; Gilmour, J.; Schlech, W.F., 3rd; Choudhri, S.; et al. A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome. Eur. J. Clin. Nutr. 2006, 60, 1266-1276. (Pubitemid 44669694)
7. Fawzi, W.W.; Msamanga, G.I.; Spiegelman, D.; Wei, R.; Kapiga, S.; Villamor, E.; Mwakagile, D.; Mugusi, F.; Hertzmark, E.; Essex, M.; et al. A randomized trial of multivitamin supplements and hiv disease progression and mortality. N. Engl. J. Med. 2004, 351, 23-32. (Pubitemid 38857244)
8. Foster, B.; Francovic, A.; Drouin, C.; Akhtar, H.; Cameron, W. Trans-b-carotene and Retinoids can Effect Human Cytochrome p450 3a4-Mediated Metabolism (Abstract tupeb4564). In Proceedings of XIV International AIDS Conference, Barcelona, Spain, 7-12 July 2002.
9. Ruhl, R.; Sczech, R.; Landes, N.; Pfluger, P.; Kluth, D.; Schweigert, F.J. Carotenoids and their metabolites are naturally occurring activators of gene expression via the pregnane x receptor. Eur. J. Nutr. 2004, 43, 336-343. (Pubitemid 40064269)
10. Kerr, B.; Yuen, G.; Daniels, R.; Quart, B.; Anderson, R. Strategic Approach to Nelfinavir Mesylate (nfv) Drug Interactions Involving cyp3a Metabolism (Abstract 429). In Proceedings of 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, USA, 22-26 January 1997.
11. Zhang, K.E.; Wu, E.; Patick, A.K.; Kerr, B.; Zorbas, M.; Lankford, A.; Kobayashi, T.; Maeda, Y.; Shetty, B.; Webber, S. Circulating metabolites of the human immunodeficiency virus protease inhibitor nelfinavir in humans: Structural identification, levels in plasma, and antiviral activities. Antimicrob. Agents Chemother. 2001, 45, 1086-1093. (Pubitemid 32230986)
12. Regazzi, M.; Maserati, R.; Villani, P.; Cusato, M.; Zucchi, P.; Briganti, E.; Roda, R.; Sacchelli, L.; Gatti, F.; Delle Foglie, P.; et al. Clinical pharmacokinetics of nelfinavir and its metabolite m8 in human immunodeficiency virus (hiv)-positive and HIV-hepatitis c virus-coinfected subjects. Antimicrob. Agents Chemother. 2005, 49, 643-649. (Pubitemid 40175675)
13. Meyers, D.G.; Maloley, P.A.; Weeks, D. Safety of antioxidant vitamins. Arch. Intern. Med. 1996, 156, 925-935. (Pubitemid 26149120)
14. van Heeswijk, R.P.; Khaliq, Y.; Gallicano, K.D.; Bourbeau, M.; Seguin, I.; Phillips, E.J.; Cameron, D.W. The pharmacokinetics of nelfinavir and m8 during pregnancy and post partum. Clin. Pharmacol. Ther. 2004, 76, 588-597. (Pubitemid 39601548)
15. Dimitrov, N.V.; Meyer, C.; Ullrey, E.; Chenoweth, W.; Michelakis, A.; Malone, W.; Boone, C.; Fink, G. Bioavailability of beta-carotene in humans. Am. J. Clin. Nutr. 1988, 48, 298-304.
16. van Het Hof, K.H.; West, C.E.; Weststrate, J.A.; Hautvast, J.G. Dietary factors that affect the bioavailability of carotenoids. J. Nutr. 2000, 130, 503-506. (Pubitemid 30118062)
17. Ribaya-Mercado, J.D.; Solon, F.S.; Solon, M.A.; Cabral-Barza, M.A.; Perfecto, C.S.; Tang, G.; Solon, J.A.; Fjeld, C.R.; Russell, R.M. Bioconversion of plant carotenoids to vitamin a in filipino school-aged children varies inversely with vitamin a status. Am. J. Clin. Nutr. 2000, 72, 455-465. (Pubitemid 30620652)
18. Lemke, S.L.; Dueker, S.R.; Follett, J.R.; Lin, Y.; Carkeet, C.; Buchholz, B.A.; Vogel, J.S.; Clifford, A.J. Absorption and retinol equivalence of b-carotene in humans is influenced by dietary vitamin a intake. J. Lipid. Res. 2003, 44, 1591-1600. (Pubitemid 37279605)
19. Wang, X.D.; Marini, R.P.; Hebuterne, X.; Fox, J.G.; Krinsky, N.I.; Russell, R.M. Vitamin e enhances the lymphatic transport of beta-carotene and its conversion to vitamin a in the ferret. Gastroenterol 1995, 108, 719-726.
20. Borel, P. Genetic variations involved in interindividual variability in carotenoid status. Mol. Nutr. Food Res. 2011, 55, 1-13.
21. Masimirembwa, C.; Bertilsson, L.; Johansson, I.; Hasler, J.A.; Ingelman-Sundberg, M. Phenotyping and genotyping of s-mephenytoin hydroxylase (cytochrome p450 2c19) in a shona population of zimbabwe. Clin. Pharmacol. Ther. 1995, 57, 656-661.
22. Persson, I.; Aklillu, E.; Rodrigues, F.; Bertilsson, L.; Ingelman-Sundberg, M. S-mephenytoin hydroxylation phenotype and cyp2c19 genotype among ethiopians. Pharmacogenetics 1996, 6, 521-526. (Pubitemid 27032304)
23. Goldstein, J.A.; Ishizaki, T.; Chiba, K.; de Morais, S.M.; Bell, D.; Krahn, P.M.; Evans, D.A. Frequencies of the defective cyp2c19 alleles responsible for the mephenytoin poor metabolizer phenotype in various oriental, caucasian, saudi arabian and american black populations. Pharmacogenetics 1997, 7, 59-64. (Pubitemid 27153320)
24. Haas, D.W.; Smeaton, L.M.; Shafer, R.W.; Robbins, G.K.; Morse, G.D.; Labbe, L.; Wilkinson, G.R.; Clifford, D.B.; D'Aquila, R.T.; De Gruttola, V.; et al. Pharmacogenetics of longterm responses to antiretroviral regimens containing efavirenz and/or nelfinavir: An adult aids clinical trials group study. J. Infect. Dis. 2005, 192, 1931-1942. (Pubitemid 41681891)
25. Khaliq, Y.; Gallicano, K.; Seguin, I.; Fyke, K.; Carignan, G.; Bulman, D.; Badley, A.; Cameron, D.W. Single and multiple dose pharmacokinetics of nelfinavir and cyp2c19 activity in human immunodeficiency virus-infected patients with chronic liver disease. Br. J. Clin. Pharmacol. 2000, 50, 108-115. (Pubitemid 30612028)
26. Droste, J.A.; Aarnoutse, R.E.; Koopmans, P.P.; Hekster, Y.A.; Burger, D.M. Evaluation of antiretroviral drug measurements by an interlaboratory quality control program. J. Acquir. Immune. Defic. Syndr. 2003, 32, 287-291. (Pubitemid 36331700)
27. Alexander, M.; Newmark, H.; Miller, R.G. Oral beta-carotene can increase the number of okt4+ cells in human blood. Immunol. Lett. 1985, 9, 221-224.
28. Watzl, B.; Bub, A.; Brandstetter, B.R.; Rechkemmer, G. Modulation of human t-lymphocyte functions by the consumption of carotenoid-rich vegetables. Br. J. Nutr. 1999, 82, 383-389. (Pubitemid 29531268)
29. Chen, C.M.; Li, S.C.; Lin, Y.L.; Hsu, C.Y.; Shieh, M.J.; Liu, J.F. Consumption of purple sweet potato leaves modulates human immune response: T-lymphocyte functions, lytic activity of natural killer cell and antibody production. World J. Gastroenterol. 2005, 11, 5777-5781.
30. Corridan, B.M.; O'Donoghue, M.; Hughes, D.A.; Morrissey, P.A. Low-dose supplementation with lycopene or beta-carotene does not enhance cell-mediated immunity in healthy free-living elderly humans. Eur. J. Clin. Nutr. 2001, 55, 627-635. (Pubitemid 32776485)
31. Murata, T.; Tamai, H.; Morinobu, T.; Manago, M.; Takenaka, H.; Hayashi, K.; Mino, M. Effect of long-term administration of beta-carotene on lymphocyte subsets in humans. Am. J. Clin. Nutr. 1994, 60, 597-602. (Pubitemid 24313008)
32. Watson, R.R.; Prabhala, R.H.; Plezia, P.M.; Alberts, D.S. Effect of beta-carotene on lymphocyte subpopulations in elderly humans: Evidence for a dose-response relationship. Am. J. Clin. Nutr. 1991, 53, 90-94. (Pubitemid 21917614)
33. Omenn, G.S.; Goodman, G.E.; Thornquist, M.D.; Balmes, J.; Cullen, M.R.; Glass, A.; Keogh, J.P.; Meyskens, F.L.; Valanis, B.; Williams, J.H.; et al. Effects of a combination of beta carotene and vitamin a on lung cancer and cardiovascular disease. N. Engl. J. Med. 1996, 334, 1150-1155. (Pubitemid 26137973)
34. Akhtar, M.; Bryan, M. Extraction and quantification of major carotenoids in processed foods and supplements by liquid chromatography. Food Chem. 2008, 111, 255-261.
35. Baede-van Dijk, P.A.; Hugen, P.W.; Verweij-van Wissen, C.P.; Koopmans, P.P.; Burger, D.M.; Hekster, Y.A. Analysis of variation in plasma concentrations of nelfinavir and its active metabolite m8 in hiv-positive patients. AIDS 2001, 15, 991-998. (Pubitemid 32476666)
36. Droste, J.A.; Verweij-Van Wissen, C.P.; Burger, D.M. Simultaneous determination of the hiv drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite m8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography. Ther. Drug Monit. 2003, 25, 393-399. (Pubitemid 36638188)
37. Piscitelli, S.C.; Rodvold, K.A.; Pai, M.P. Drug Interactions in Infectious Diseases, 3rd ed.; Humana Press: Totowa, NJ, USA, 2011.
38. FDA, Department of Health and Human Services. Guidance for Industry-In vivo Drug Metabolism / Drug Interaction Studies-Study Design, Data Analysis, and Recommendations for Dosing and Labeling; FDA: Rockville, MD, USA, 1999; pp. 1-16.